Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparing Palliative Radiotherapy With or Without Carboplatin
Sponsor: Institut Cancerologie de l'Ouest
Summary
The study population has locally advanced or metastatic bronchial or head and neck cancer. This study assesses the value of concomitant chemo/radiotherapy with carboplatin daily during metastatic radiotherapy versus radiotherapy alone. The realization of a systemic treatment during the radiotherapy could make it possible to obtain a benefit on the control of the evolution of the metastases and thus of the pains generated, as well as on the quality of life of the patients. In addition, a benefit in overall survival is possible.
Official title: Phase-3 Study, Randomized, Controlled, Multi-center, Double Blind, Comparing Palliative Radiotherapy With or Without Carboplatin
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
26
Start Date
2015-08-17
Completion Date
2018-05-28
Last Updated
2026-06-09
Healthy Volunteers
No
Interventions
irradiation + carboplatin
30 Gy en 10 fractions de 3 Gy + 10 injections of carboplatin
irradiation + placebo
30 Gy en 10 fractions de 3 Gy + 10 injections of placebo
Locations (2)
Fabrice Denis
Le Mans, France
Institut de Cancérologie de l'Ouest
Nantes, France